Nuwellis Appoints John Erb as Chief Executive Officer

Core Points - Nuwellis, Inc. has appointed John Erb as Chief Executive Officer, effective June 27, 2025, after serving as interim CEO since February 2025 [1][2] - Erb previously held the CEO position from 2015 to 2020, and his reappointment indicates the Board's confidence in his leadership and understanding of the company's mission [2] - Under Erb's interim leadership, the company has experienced stability and renewed momentum [2] Company Overview - Nuwellis, Inc. is a medical technology company focused on fluid management solutions, particularly the Aquadex SmartFlow system for ultrafiltration therapy [4] - The company is headquartered in Minneapolis and has a wholly owned subsidiary in Ireland [4] Product Information - The Aquadex SmartFlow system is designed to remove excess fluid from patients suffering from hypervolemia, with indications for both temporary (up to 8 hours) and extended use [5] - The system is intended for adult and pediatric patients weighing 20 kg or more, whose fluid overload is unresponsive to medical management, including diuretics [5]